eMERGE is a national network organized and funded by the National Human Genome Research Institute (NHGRI) that combines DNA biorepositories with electronic medical record (EMR) systems for large scale, high-throughput genetic research in support of implementing genomic medicine.
Many factors contribute to risk of a disease. Some of these factors are internal, like genetics, and others are external, like where someone lives. Over the last several years researchers have discovered that in addition to one gene being associated with a given disease (monogenic factors), many genes across your genome can contribute to the development of a disease (polygenic factors). To learn more about elements that contribute to risk a disease, click here.
Latest News
Invitae to partner with eMERGE as a clinical affiliate to investigate monogenic risk of conditions
April 4, 2021 4:58 PM
Dr. Lori Orlando 2021 PROSE Award Recognition
March 3, 2021 1:11 PM
Lessons Learned from eMERGE III
January 1, 2021 3:53 PM
NHGRI announces the next round of the eMERGE Network
July 7, 2020 2:19 PM
Publication Update: MCS NT304 published in the American Journal of Human Genetics
May 5, 2020 1:09 PM
eMERGE Network: RFA Publications
March 3, 2020 1:50 PM
MORE NEWS
Recent Publications
Sanchez-Roige S, Cox NJ, Johnson EO, Hancock DB, Davis LK. Alcohol and cigarette smoking consumption as genetic proxies for alcohol misuse and nicotine dependence. Drug and alcohol dependence. 2021 Apr 1;221:108612.
Pacyna JE, Shaibi GQ, Lee A, Byrne JO, Sharp RR, et al. Increasing access to individualized medicine: a matched-cohort study examining Latino participant experiences of genomic screening. Genetics in medicine : official journal of the American College of Medical Genetics. 2021 Jan 26;.
MORE PUBLICATIONS